Normal view MARC view ISBD view

Epoprostenol (PGI2) prevents postischemic ventricular fibrillation and improves outcome in a canine model of sudden death.

Jouve, R

Epoprostenol (PGI2) prevents postischemic ventricular fibrillation and improves outcome in a canine model of sudden death. [electronic resource] - Journal de pharmacologie - 139-57 p. digital

Publication Type: Journal Article

ISSN: 0021-793X

Subjects--Topical Terms:
Animals
Death, Sudden
Disease Models, Animal
Dogs
Electrocardiography
Epoprostenol--pharmacology
Female
Hemodynamics--drug effects
Male
Platelet Aggregation--drug effects
Time Factors
Ventricular Fibrillation--prevention & control

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)